Pages that link to "Q37061588"

The following pages link to The TGFBeta pathway as a therapeutic target in cancer. (Q37061588):

Displaying 26 items.

• USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma (Q24305427) (← links)
• Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway (Q26797238) (← links)
• Transient tumor-fibroblast interactions increase tumor cell malignancy by a TGF-Beta mediated mechanism in a mouse xenograft model of breast cancer (Q27332206) (← links)
• Raf kinases in cancer-roles and therapeutic opportunities (Q28237793) (← links)
• LASP1-S100A11 axis promotes colorectal cancer aggressiveness by modulating TGFβ/Smad signaling (Q30008914) (← links)
• USP26 regulates TGF-β signaling by deubiquitinating and stabilizing SMAD7 (Q33625848) (← links)
• Cytokine-driven loss of plasmacytoid dendritic cell function in chronic lymphocytic leukemia (Q33910990) (← links)
• Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer. (Q33913556) (← links)
• IL-10 and TGF-beta redundantly protect against severe liver injury and mortality during acute schistosomiasis (Q34064182) (← links)
• Strong impact of TGF-β1 gene polymorphisms on breast cancer risk in Indian women: a case-control and population-based study (Q35022568) (← links)
• NF-κB induces miR-148a to sustain TGF-β/Smad signaling activation in glioblastoma (Q35599399) (← links)
• Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling (Q36140792) (← links)
• TGF-β induces miR-182 to sustain NF-κB activation in glioma subsets. (Q36659217) (← links)
• The harmonies played by TGF-β in stem cell biology (Q36730830) (← links)
• Stromal Modulators of TGF-β in Cancer (Q37628179) (← links)
• TGF-beta signalling and immunity in prostate tumourigenesis (Q37670250) (← links)
• Prime-boost immunization by both DNA vaccine and oncolytic adenovirus expressing GM-CSF and shRNA of TGF-β2 induces anti-tumor immune activation (Q37716633) (← links)
• TRAF4 mediates activation of TGF-β signaling and is a biomarker for oncogenesis in breast cancer (Q38253588) (← links)
• Overactivation of the TGF-β pathway confers a mesenchymal-like phenotype and CXCR4-dependent migratory properties to liver tumor cells. (Q39132780) (← links)
• Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97‐H cell line (Q39644929) (← links)
• Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis. (Q39753483) (← links)
• CCAAT enhancer binding protein β has a crucial role in regulating breast cancer cell growth via activating the TGF-β-Smad3 signaling pathway (Q40092497) (← links)
• Unusual early-stage pancreatic sarcomatoid carcinoma (Q41873064) (← links)
• The HPV16 E6 oncoprotein and UVB irradiation inhibit the tumor suppressor TGFβ pathway in the epidermis of the K14E6 transgenic mouse (Q42154608) (← links)
• The TGFβ pathway stimulates ovarian cancer cell proliferation by increasing IGF1R levels. (Q51703872) (← links)
• Targeting TGF-beta in prostate cancer: therapeutic possibilities during tumor progression (Q57142667) (← links)